Stocks of IDEXX Laboratories - Current price, Where to buy? Chart
| Detail | Data |
|---|---|
| Stocks: | IDEXX Laboratories |
| ompany Name: | IDEXX Laboratories, Inc. |
| Ticker: | IDXX |
| Exchange: | NasdaqGS |
| Outstanding stocks: | 82,587,296 |
| 24-hour Volume: | 427,947 |
| Industry: | Diagnostics & Research |
| Sector: | Healthcare |
| Number of Employees: | 11000 |
| Country: | United States |
| City: | Westbrook |
| Address: | One IDEXX Drive |
| P/E Ratio: | Forward P/E | EPS: | Forward EPS | Book value per share | Market capitalization |
|---|---|---|---|---|---|
| 46.54 | 38.33 | 10.33 USD | 12.54 USD | 18.93 USD | 39,674,523,648.00 USD |
| P/E Ratio: | 46.54 |
|---|---|
| Forward P/E: | 38.33 |
| EPS: | 10.33 USD |
| Forward EPS: | 12.54 |
| Book value per share: | 18.93 USD |
| Market capitalization: | 39,674,523,648.00 USD |
IDEXX Laboratories
Fundamental Indicators
| Indicator | Data |
|---|---|
| Total Revenue: | 3,724,852,992.00 USD |
| Net Income: | 866,566,976.00 USD |
| Price-to-Book (P/B) Ratio: | 25.39 |
| PEG Ratio: | 3.59 |
Note: The data is approximate, subject to change over time, and may not be current; however, we strive for the highest possible accuracy.
Analysts' predictions
| Analysts | Recommendation |
|---|---|
| Issued Recommendation: | According to our data, the recommendation issued for IDEXX Laboratories stocks is: buy |
| Number of Analysts: | 9 |
| Highest Target Price: | 641 USD |
| Lowest Target Price: | 460 USD |
| Average Target Price: | 600 USD |
Note: The data is approximate. Recommendations and price forecasts for IDEXX Laboratories stocks based on analysts' ratings may change over time. Some recommendations may already be outdated and may not be accurate. We strongly advise against buying and selling stocks based on analysts' recommendations!
Dividend
| Dividends | Value |
|---|---|
| Dividend Amount | According to our data, the company IDEXX Laboratories is currently not paying dividends. |
| Annual Yield %: | - |
| Ex-dividend Date: | - |
| Average % Yield for 5 Years: | - |
| Payout Ratio: | - |
| Value of Last Dividend Paid: | - |
| Date of Last Dividend: | - |
The dividend is displayed for the entire calendar year, however, it is usually paid out quarterly in parts. Data may change!
Where to Buy IDEXX Laboratories Stocks?
If you're interested in investing in IDEXX Laboratories stocks and believe in their future growth, you can purchase them through stock brokers like XTB or eToro. To make buying easier, we've prepared a table with offers from these brokers, including quick purchase of IDEXX Laboratories stocks through mobile apps with client support. In this table, you can compare brokers offering real IDEXX Laboratories stocks. Brokers providing the option to buy real stocks (not CFDs) are identified by "Real Stocks" in the comparison table column.
| Broker | Platforms | Regulation | Min. Deposit | Deposits / Withdrawals | CopyTrader | Real Stocks | Website Link |
|---|---|---|---|---|---|---|---|
 |
Proprietary platform, social network + CopyTrader™ | 100 USD | Bank transfer, credit cards, Skrill, PayPal, Neteller |
 Go to eToro
|
|||
 |
xStation, mobile version | 10 USD | Credit cards, Skrill, bank transfer |
 Go to XTB
|
|
|
| xStation, mobile version | Proprietary platform, social network + CopyTrader™ |
|
Go to XTB
|
Go to eToro
|
More Information about IDEXX Laboratories (IDXX)
IDEXX Laboratories consistently proves itself as a leader in its industry. Total revenues for the last 12 months exceed 3,724,852,992.00 USD, demonstrating its strong market position and ability to generate high revenues. With EBITDA reaching 1,232,167,936.00 USD, IDEXX Laboratories maintains a high level of efficiency and profitability. This highlights its ability to manage operational costs effectively. Debt-to-equity ratio of 0.68 suggests that IDEXX Laboratories has a healthy financial structure and effectively manages its debts. This is key to stable growth. Gross margin of 60.14% shows that IDEXX Laboratories efficiently manages costs and maintains a high share of revenues. This is a sign of a strong market position. Profit margin of 23.26% underscores IDEXX Laboratories's efficiency in converting revenues into net income, which is crucial for its prosperity.
| Indicator | Value |
|---|---|
| Revenue, Debt, and Cash Flow | |
| Company Revenue: | 3,724,852,992.00 USD |
| EBITDA: | 1,232,167,936.00 USD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization. |
| Earnings Per Share: | 10.33 USD |
| Book Value Per Share: | 18.93 USD |
| Total Cash: | 397,432,992.00 USD |
| Total Cash per Share: | 4.81 USD |
| Total Debt: | 1,068,942,016.00 USD |
| Debt to Equity Ratio: | 0.68 |
| Quick Ratio: | 1.02 |
| Current Ratio: | 1.57 |
| Free Cash Flow: | 733,090,240.00 USD |
| Operating Cash Flow: | 921,182,976.00 USD |
| Company Margins | |
| Gross Margins: | 60.14 % |
| EBITDA Margins: | 33.08 % |
| Operating Margins: | 31.01 % |
| Profit Margins: | 23.26 % |
| Performance | |
| Return on Assets: | 22.6 % |
| Return on Equity: | 71.9 % |
| Earnings Growth (1 year): | 10.2% |
| Revenue Growth (1 year): | 7.1 % |
| Year-over-Year Quarterly Earnings Growth: | 10.1 % |
| Valuation | |
| Market Capitalization: | 39,674,523,648.00 USD |
| Enterprise Value: | 39,968,210,944.00 USD |
| EV/Revenue: | 10.73 |
| EV/EBITDA: | 32.437 |
| Number of Shares and Short Shares | |
| Float Shares: | 81,689,604 shares |
| Shares Outstanding: | 82,587,296 shares |
| Held Percent Insiders: | 0.01 % |
| Held Percent Institutions: | 92.64 % |
| Shares Short: | 1,711,390 |
| Shares Short Prior Month: | 1,803,921 |
| Date Short Interest: | 2024-04-15 |
| Shares Percent Shares Out: | 2.07 % |
| Short Ratio: | 4.26 |
| Beta: | 1.26 |
| Short Percent of Float: | 2.65 % |
| Předpokládaný počet akcií: | 82,587,296 |
Frequently Asked Questions (FAQ)
According to our data, IDEXX Laboratories does not currently pay dividends, even in 2024.
IDEXX Laboratories shares are traded on the stock exchange NasdaqGS under the ticker symbol: IDXX. You can buy or trade them with a variety of stock brokers offering real stock trading services.
According to our data, there is a buy recommendation issued for IDEXX Laboratories shares by a total of 9 analysts. The average target price prediction is 600 USD per share.
The total number of IDEXX Laboratories shares on the exchange is 82,587,296.00, which, at the current market capitalization, values the company at 39,674,523,648.00 USD.
